View Author
patient transplant mycophenolic acid transplantation study diarrhea mycophenolic concentration method mycophenolate mofetil assay group month transplant recipients mycophenolate plasma mofetil visit recipient lc –ms acmpag diarrhoea metabolite figure mpa-auc mmf dose signi ficantly signi episode glucuronide +++ event cyclosporine mpa assay incidence tacrolimu armstrong vw roche value signi ficant differences tcl /mmf exposure difference fi xed dose comparison table drug monitoring analysis center trial plasma concentrations department kidney result immunoassay monit csa /mmf enterohepatic recycling mmf doses point fdcc study biliary excretion drug monit rejection regimen ficantly ficant j transplant signi ficant difference monitoring sample american mpa concentrations research support tcl /mmf regimen range pharmacokinetic control journal university
2 Most Recent Publications
|
Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized lc-ms/ms method
(Article)
Gelder, T. van Domke, I. Engelmayer, J. Fijter, H.D. Kuypers, D. Budde, K. Koeger, R. Luthe, H. Oellerich, M. |
2009-04-01
|
|
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients
(Article)
Heller, T. Gelder, T. van MacPhee, I.A.M. Pohanka, E. Engelmayer, J. Brandhorst, G. Oellerich, M. Armstrong, V.W. Budde, K. Fijter, J.W. de Kuypers, D. Arns, W. Schmidt, J. Rostaing, L. Powis, S.H. Claesson, K. |
2007-07-01
|